The TRIPS Tightrope public health, innovation, incentives and access
|
|
- Darren Weaver
- 5 years ago
- Views:
Transcription
1 International Federation of Pharmaceutical Manufacturers & Associations The TRIPS Tightrope public health, innovation, incentives and access Helsinki, 6 September IFPMA 2013
2 Definitions (I) Doha declaration Paragraph 5 we recognize that these flexibilities include: In applying the customary rules of interpretation of public international law, each provision (...) shall be read in the light of the object and purpose of the Agreement (...). Each member has the right to grant compulsory licences and the freedom to determine the grounds upon which such licences are granted. Each member has the right to determine what constitutes a national emergency or other circumstances of extreme urgency (...). The effect of the provisions in the TRIPS Agreement that are relevant to the exhaustion of intellectual property rights is to leave each member free to establish its own regime for such exhaustion (...).
3 Definitions (II) Chairman s summary at approval of Paragraph 6 Mechanism: (...)Members recognize that the system that will be established by the Decision should be used in good faith to protect public health and, without prejudice to paragraph 6 of the Decision, not be an instrument to pursue industrial or commercial policy objectives.
4 The early IP and health debate
5 An industry view (2000) Argentina remains the worst expropriator of the intellectual property of the research-based pharmaceutical industry in the Western Hemisphere, and one of the worst in the world. It intentionally permits the local industry to copy innovative pharmaceutical products immediately, without permission of the innovator and without having to expend resources for research and development to prove safety and efficacy.
6 An industry view (2013) [The pharmaceutical industry] recognizes that India has legitimate concerns regarding access to healthcare throughout the country and we acknowledge the challenges of the Government to make essential medicines available to the most vulnerable sections of society. However, we are concerned about inadequate intellectual property (IP) protections, including the recent issuance of a compulsory license, which pose significant market access barriers in India.
7 The new criticism of the IP system
8 Change was not only in semantics Today, most companies that own IPRs covering products for the treatment of HIV/AIDS have signed licence or immunity-from-suit agreements with various generic producers, or have issued non-assert declarations on their HIV/AIDS products. (Trilateral Study, p.180) 8 IFPMA 2013
9 International Partnerships 9 IFPMA 2013
10 14 billion treatments to be donated until IFPMA 2013
11 Access to Medicines: A Shared Objective Definition: timely availability, under varied physical and economic conditions, of quality drugs to patients in need Many inter-related factors determine access level: Health Care Systems Government Policies Infrastructure & Supply Medicines 11
12 Access to Medicines: A complex Picture Source: Levison, L and Laing, R Essential Drugs Monitor No Available at: at 12 IFPMA 2013
13 Medicines are just a part of the healthcare puzzle 13 IFPMA 2012
14 IMS: Half trillion dollar opportunity in avoidable healthcare system costs 14 IFPMA 2012
15 Are we going back to the starting point India statement at the WTO TRIPS Council, March 2013 It is unfortunate that some of the technologically developed countries would like to show case the positive effect of IP on innovation, when historically these countries including the proponents of this Agenda Item [IP and Innovation] have reached this stage of technological development by focussing solely on the development of their own domestic industry without caring for the intellectuals property rights of the foreigners or the right holders. After achieving a high level of development, they are now attempting to perpetuate their hold on their technologies by making a push towards a TRIPS plus regime. Their agenda is not to create an environment where developing countries progress technologically, but to block their progress through the stringent IP regime. It is therefore essential that the flexibilities provided by the TRIPS Agreement need to be secured at any cost, if the people in the developing countries are to enjoy the benefits of innovations. 15 May 11, 2012 IFPMA 2012
IPRs and Public Health: Lessons Learned Current Challenges The Way Forward
Local Pharmaceutical Production in Africa International Conference Cape Town, 4-6 April 2011 IPRs and Public Health: Lessons Learned Current Challenges The Way Forward Roger Kampf WTO Secretariat 1 Acknowledging
More informationProtecting Intellectual Property under TRIPS, FTAs and BITs: Conflicting Regimes or Mutual Coherence?
Protecting Intellectual Property under TRIPS, FTAs and BITs: Conflicting Regimes or Mutual Coherence? Henning Große Ruse International Investment Treaty Law and Arbitration Conference Sydney, 19-20 February
More informationWTO NEGOTIATIONS ON TRIPS AND PUBLIC HEALTH: AN OVERVIEW. Jayashree Watal WTO Secretariat
WTO NEGOTIATIONS ON TRIPS AND PUBLIC HEALTH: AN OVERVIEW Jayashree Watal WTO Secretariat Outline Background to discussions in the TRIPS Council, including WHO-WTO Workshop on Differential Pricing and Financing
More informationDr. Biswajit Dhar Professor, Jawaharlal Nehru University, India and Member DA9 Advisory Board
Dr. Biswajit Dhar Professor, Jawaharlal Nehru University, India and Member DA9 Advisory Board Intellectual Property Rights in Preferential Trade Agreements Many Preferential Trade Agreements (PTAs) adopted
More informationTRIPS, FTAs and BITs: Impact on Domestic IP- and Innovation Strategies in Developing Countries
Innovation, Creativity and IP Policy: An Indo-European Dialogue TRIPS, FTAs and BITs: Impact on Domestic IP- and Innovation Strategies in Developing Countries Henning Grosse Ruse NUJS & MPI Collaborative
More informationStanding Committee on the Law of Patents Twenty-Sixth Session
Standing Committee on the Law of Patents Twenty-Sixth Session Marco M. ALEMAN Director, Patent Law Division, WIPO Geneva, July 3 to 6, 2017 SCP/26/5 CONSTRAINTS FACED BY DEVELOPING COUNTRIES AND LEAST
More informationTRAINING SEMINAR PHARMACEUTICALS AND INTELLECTUAL PROPERTY ACCESS TO MEDICINE: Exploitation of pharmaceutical patents: compulsory licences SESSION 4
TRAINING SEMINAR PHARMACEUTICALS AND INTELLECTUAL PROPERTY 1 12 14 March 2012 Pretoria, South Africa SESSION 4 ACCESS TO MEDICINE: COMMERCIALISATION, DISTRIBUTION, COMPETITION ----------------- Exploitation
More informationStanding Committee on the Law of Patents
E SCP/24/4 ORIGINAL: ENGLISH DATE: JUNE 29, 2016 Standing Committee on the Law of Patents Twenty-Fourth Session Geneva, June 27 to 30, 2016 PROPOSAL BY THE AFRICAN GROUP FOR A WIPO WORK PROGRAM ON PATENTS
More information19 Progressive Development of Protection Framework for Pharmaceutical Invention under the TRIPS Agreement Focusing on Patent Rights
19 Progressive Development of Protection Framework for Pharmaceutical Invention under the TRIPS Agreement Focusing on Patent Rights Research FellowAkiko Kato This study examines the international protection
More informationB) Issues to be Prioritised within the Proposed Global Strategy and Plan of Action:
INTERGOVERNMENTAL WORKING GROUP ON PUBLIC HEALTH, INNOVATION AND INTELLECTUAL PROPERTY EGA Submission to Section 1 Draft Global Strategy and Plan of Action The European Generic Medicines Association is
More informationIntellectual Property
Intellectual Property Johnson & Johnson believes that the protection of intellectual property (IP) is essential to rewarding innovation and promoting medical advances. We are committed: to raising awareness
More informationAn overview of India's approach to key IP issues at home and abroad. Dr. Bona Muzaka King s College London
An overview of India's approach to key IP issues at home and abroad Dr. Bona Muzaka King s College London valbona.muzaka@kcl.ac.uk Why Intellectual Property? Why India? UNITAID (patent pools since 2008,
More informationCompulsory Licensing:
HESO 449B Compulsory Licensing: An effective tool to increasing access to essential medicines? Julia Wu Submitted on April 7 th, 2010 Realizing that patent protection on pharmaceutical products can restrict
More informationTRIPs & PATENTS. In 1899, Mr. Charles H. Duell, Director of US Patent office said Everything that can be invented, has (already) been invented.
TRIPs & PATENTS Dr.Gopakumar G. Nair In 1899, Mr. Charles H. Duell, Director of US Patent office said Everything that can be invented, has (already) been invented. The events thereafter proved that inventions
More information2.5.2 NON-DISCRIMINATION (ARTICLE 27.1)
2.5.2 NON-DISCRIMINATION (ARTICLE 27.1) Article 27.1: Patentable Subject Matter... patents shall be available and patent rights enjoyable without discrimination as to the place of invention, the field
More informationCarnegie Endowment for International Peace
Carnegie Endowment for International Peace How the U.S. and India could Collaborate to Strengthen Their Bilateral Relationship in the Pharmaceutical Sector Second Panel: Exploring the Gilead-India Licensing
More informationFlexibilities in the Patent System
Flexibilities in the Patent System Dr. N.S. Gopalakrishnan Professor, HRD Chair on IPR School of Legal Studies, Cochin University of Science & Technology, Cochin, Kerala 1 Introduction The Context Flexibilities
More informationGlobal strategy and plan of action on public health, innovation and intellectual property
SIXTY-FIRST WORLD HEALTH ASSEMBLY WHA61.21 Agenda item 11.6 24 May 2008 Global strategy and plan of action on public health, innovation and intellectual property The Sixty-first World Health Assembly,
More informationAccess to Medicines, Patent Information and Freedom to Operate
TECHNICAL SYMPOSIUM DATE: JANUARY 20, 2011 Access to Medicines, Patent Information and Freedom to Operate World Health Organization (WHO) Geneva, February 18, 2011 (preceded by a Workshop on Patent Searches
More informationAccess to Technology in the Post-2015 Development Agenda. Alessandra Casazza Policy Advisor UNDP Asia-Pacific Regional Center
Access to Technology in the Post-2015 Development Agenda Alessandra Casazza Policy Advisor UNDP Asia-Pacific Regional Center TECHNOLOGY IS ESSENTIAL FOR ACHIEVING SUSTAINABLE DEVELOPMENT MDG 8 ICT & Access
More informationThe stakes within diverse global policy deliberations concerning treatment of Intellectual Property related to standard-setting
The stakes within diverse global policy deliberations concerning treatment of Intellectual Property related to standard-setting ANSI CMF/ICSCA Meeting Agenda 3.4 Miami, Florida: April 10, 2008 Presented
More informationVirtual Mentor American Medical Association Journal of Ethics December 2006, Volume 8, Number 12:
Virtual Mentor American Medical Association Journal of Ethics December 2006, Volume 8, Number 12: 834-838. Health law Intellectual property and access to medicine for the poor by Tara Leevy, LLB, LLM India
More informationRegional Seminar for Certain African Countries on the Implementation and Use of Several Patent-Related Flexibilities
REPUBLIC OF SOUTH AFRICA Regional Seminar for Certain African Countries on the Implementation and Use of Several Patent-Related Flexibilities Topic 15: The Impact of National Exhaustion of Rights on the
More informationWHO workshop on IP and Vaccines. Geneva 19 th -20 th April Introduction to the IP issues Christopher Garrison Consultant to WHO
WHO workshop on IP and Vaccines Geneva 19 th -20 th April 2004 Introduction to the IP issues Christopher Garrison Consultant to WHO Vaccine access, R&D and technology transfer issues are intimately linked
More informationIP Strategies to Enhance Competitiveness: India s Experience
IP Strategies to Enhance Competitiveness: India s Experience N. N. Prasad Wednesday July 15, 2009 Innovation in Brazil, India and South Africa: A New Drive for Economic Growth and Development Strategy
More informationEstablishing a Development Agenda for the World Intellectual Property Organization
1 Establishing a Development Agenda for the World Intellectual Property Organization to be submitted by Brazil and Argentina to the 40 th Series of Meetings of the Assemblies of the Member States of WIPO
More informationPROTECTION OF INTELLECTUAL PROPERTY
Chapter 12 PROTECTION OF INTELLECTUAL PROPERTY OVERVIEW OF RULES In today s economic environment, intangible assets are becoming increasingly important. These assets, which are the result of human intellectual
More informationAn Essential Health and Biomedical R&D Treaty
An Essential Health and Biomedical R&D Treaty Submission by Health Action International Global, Initiative for Health & Equity in Society, Knowledge Ecology International, Médecins Sans Frontières, Third
More informationTRIPS FLEXIBILITIES AND ACCESS TO MEDICINES
TRIPS FLEXIBILITIES AND ACCESS TO MEDICINES A European Approach Acknowledgements We are grateful to Ellen t Hoen for reviewing an earlier version of this brochure. Publisher Health Action International
More informationTopic 2: Patent-related Flexibilities in Multilateral Treaties and Their Importance for Developing Countries and LDCs
Topic 2: Patent-related Flexibilities in Multilateral Treaties and Their Importance for Developing Countries and LDCs McLean Sibanda Chief Executive Officer - The Innovation Hub Second WIPO Inter-Regional
More informationThe TRIPS Agreement and Patentability Criteria
WHO-WIPO-WTO Technical Workshop on Patentability Criteria Geneva, 27 October 2015 The TRIPS Agreement and Patentability Criteria Roger Kampf WTO Secretariat 1 Trilateral Cooperation: To Build Capacity,
More informationChapter 15: Access to essential medicines, TRIPS and the patent system
Chapter 15: Access to essential medicines, TRIPS and the patent system SUMMARY POINTS All countries should develop a national medicines policy that includes a national list of essential medicines that
More informationTRIPS and Access to Medicines. The Story so far
TRIPS and Access to Medicines The Story so far TRIPS and Access to Medicines : A brief history 1981: HIV first clinically observed 1982-83: Named AIDS 1984: Discovery that it is caused by a virus 1986:
More informationGENEVA WIPO GENERAL ASSEMBLY. Thirty-First (15 th Extraordinary) Session Geneva, September 27 to October 5, 2004
WIPO WO/GA/31/11 ORIGINAL: English DATE: August 27, 2004 WORLD INTELLECTUAL PROPERT Y O RGANI ZATION GENEVA E WIPO GENERAL ASSEMBLY Thirty-First (15 th Extraordinary) Session Geneva, September 27 to October
More informationMr. Marco Aleman Director, Patent Law Division World Intellectual Property Organization 34, chemin des Colombettes 1211 Geneva 20 Switzerland
Mr. Marco Aleman Director, Patent Law Division World Intellectual Property Organization 34, chemin des Colombettes 1211 Geneva 20 Switzerland Dear Mr. Aleman As an observer to WIPO s Standing Committee
More informationFixing Canada s Access to Medicines Regime (CAMR): 20 Questions & Answers
Fixing Canada s Access to Medicines Regime (CAMR): 20 Questions & Answers In this document: Questions 1 to 4 give a quick overview of CAMR and why it needs to be fixed. Questions 5 to 11 provide more in-depth,
More informationDraft Plan of Action Chair's Text Status 3 May 2008
Draft Plan of Action Chair's Text Status 3 May 2008 Explanation by the Chair of the Drafting Group on the Plan of Action of the 'Stakeholder' Column in the attached table Discussed Text - White background
More informationTRIPS and Access to Medicines. WR Briefing
TRIPS and Access to Medicines WR Briefing Outline What is TRIPS How does it affect access to medicines What are the TRIPS flexibilities? What are extra-trips provisions? How do the extra-trips provisions
More informationMagdalena Krawczyk. Compulsory Licensing of Pharmaceuticals since the Doha Declaration a Public Health Triumph or Failure? Abstract.
Zeszyty Naukowe Towarzystwa Doktorantów UJ Nauki Społeczne, Numer 15 (4/2016) Magdalena Krawczyk Jagiellonian University Faculty of Law and Administration The Intellectual Property Law Chair e-mail: magda.krawczyk@doctoral.uj.edu.pl
More informationUNITAID The HIV/AIDS Medicines Patent Pool Initiative Overview
UNITAID The HIV/AIDS Medicines Patent Pool Initiative Overview December 2009 UNITAID Mission UNITAID's Mission Scale up access to treatment for HIV/AIDS, malaria and TB Leverage price reductions of quality
More informationElements of a global strategy and plan of action
INTERGOVERNMENTAL WORKING GROUP A/PHI/IGWG/1/5 ON PUBLIC HEALTH, INNOVATION AND 8 December 2006 INTELLECTUAL PROPERTY Agenda item 2.3 Elements of a global strategy and plan of action Progress to date in
More informationRegional Seminar for Certain African Countries on the Implementation and Use of Several Patent-Related Flexibilities
REPUBLIC OF SOUTH AFRICA Regional Seminar for Certain African Countries on the Implementation and Use of Several Patent-Related Flexibilities Topic 7: Flexibilities Related to the Definition of Patentable
More informationAfrican Civil Society Meeting
African Civil Society Meeting Intergovernmental Working Group on Intellectual Property, Innovation and Health Topic: Considering Domestic Manufacturing Issues Nairobi Kenya 28-29 August 2007 DR W.O. WANYANGA
More informationWorld Intellectual Property Organization. Topic C: Healthcare and Pharmacological Patents
World Intellectual Property Organization Topic C: Healthcare and Pharmacological Patents The policy balance between encouraging innovation and ensuring the widespread enjoyment of the social benefit of
More information372 index. predominantly for supply of domestic market 113, 132 3, 184 5, 186; remedying anticompetitive
INDEX acceding countries 23 Access to Medicines, Patent Information and Freedom to Operate (WHO/ WIPO/WTO) 195 Access to Medicines: Pricing and Procurement Practices (WHO/WIPO/WTO) 195 Agreement on Trade-Related
More informationRole of Patents in Green Technology Transfer in the Context of Climate Change
Role of Patents in Green Technology Transfer in the Context of Climate Change Wanna Tanunchaiwatana Manager, Technology UN Climate Change Secretariat WIPO conference on Intellectual Property and Public
More informationThe Contribution of Intellectual Property to Facilitating the Transfer of Environmentally Sound Technology
Report The Contribution of Intellectual Property to Facilitating the Transfer of Environmentally Sound Technology Tuesday, 12 May 2015, Java Hill, Crozet, France Nina Fink In the line of the use and transfer
More informationTHE LEGALITY OF LOCAL PATENT WORKING REQUIREMENTS UNDER THE TRIPS AGREEMENT
THE LEGALITY OF LOCAL PATENT WORKING REQUIREMENTS UNDER THE TRIPS AGREEMENT Chia-Ling Lee * J.D. Graduate of Class 2013 Washington University in St. Louis School of Law ABSTRACT The balance between the
More informationBIPF Munich. South Africa Enforcement of Pharmaceutical Patents and the New Draft IP Policy
BIPF 2014 - Munich South Africa Enforcement of Pharmaceutical Patents and the New Draft IP Policy Russell Bagnall Danie Dohmen 1 OVERVIEW Enforcement of Pharmaceutical Patents The Role Players Compulsory
More informationDraft global strategy on public health, innovation and intellectual property
IGWG: Outcome document at 14.00 hours, Saturday 3 May 2008 Draft global strategy on public health, innovation and intellectual property The context 1. In resolution WHA59.24 the Health Assembly recognized
More informationDescriptions of Workshops and Pharma Workshops for Helsinki 2013
Descriptions of Workshops and Pharma Workshops for Helsinki 2013 1) IP licensing and insolvency The insolvency of technological giants such as Qimonda, BenQ or Kodak sends massive shockwaves into the world
More informationTRIPS Post Grant Flexibilities: Key Exceptions to Patent Holders' Rights. David Vivas Eugui
TRIPS Post Grant Flexibilities: Key Exceptions to Patent Holders' David Vivas Eugui dvivas@ictsd.ch OVERVIEW OF PRESENTATION Patent holders rights Article 30 TRIPS Agreement on patent exceptions The scientific
More informationTRIPS Agreement and its Impact on Health
SEA-HSD-277 Distribution: General TRIPS Agreement and its Impact on Health Report on a National Workshop Yangon, Myanmar, 13-15 October 2003 WHO Project: MMR EDM 001 World Health Organization Regional
More informationPharmaceutical Patents in India - Seminar on Global l Best IPR Practices Indo American Chamber of Commerce
Pharmaceutical Patents in India - Seminar on Global l Best IPR Practices Indo American Chamber of Commerce Tapan Ray March 29, 2008 - Mumbai INDIAN PHARMACEUTICAL INDUSTRY: 2006-2007 2007 U.S.$ 8 Bn. Domestic
More informationFree Trade Agreements on Public Health
UNDP, UNAIDS Issue BRIEF 2012 The Potential Impact of Free Trade Agreements on Public Health The Potential Impact of Free Trade Agreements on Public Health UNDP, UNAIDS UNAIDS / JC2349E (English original,
More informationPATENT PROTECTION FOR PHARMACEUTICAL PRODUCTS IN CANADA CHRONOLOGY OF SIGNIFICANT EVENTS
PRB 99-46E PATENT PROTECTION FOR PHARMACEUTICAL PRODUCTS IN CANADA CHRONOLOGY OF SIGNIFICANT EVENTS Margaret Smith Law and Government Division 30 March 2000 Revised 31 May 2000 PARLIAMENTARY RESEARCH BRANCH
More informationThe Copenhagen Accord and Climate Innovation Centres
Queensland University of Technology From the SelectedWorks of Matthew Rimmer January 20, 2010 The Copenhagen Accord and Climate Innovation Centres Matthew Rimmer, Australian National University College
More informationInternational Patent Regime. Michael Blakeney
Patent Regime Michael Blakeney Patent related treaties WIPO administered treaties Paris Convention (concluded 1883) Patent Cooperation Treaty (1970) Strasbourg Agreement (1971) Budapest Treaty (1977) Patent
More informationWORLD TRADE ORGANIZATION ADVANCED COURSE. WIPO-WTO/ADV/ACAD/13/INF1.PROV ORIGINAL: English DATE: XXXX
E WORLD TRADE ORGANIZATION ADVANCED COURSE -/ADV/ACAD/13/INF1.PROV ORIGINAL: English DATE: XXXX Last updated 2 December 2013 - Advanced Course on Intellectual Property for Government Officials organized
More informationEthiopia s Accession to World Trade Organization (WTO): The Need to Reform Ethiopian Patent Law to Facilitate Access to Medicine PART I
w w w. a b y s s i n i a l a w. c o m P a g e 1 Ethiopia s Accession to World Trade Organization (WTO): The Need to Reform Ethiopian Patent Law to Facilitate Access to Medicine Abstract As a country dealing
More informationIntellectual Property Rights and Development CARLOS M. CORREA
Intellectual Property Rights and Development CARLOS M. CORREA Proposal by Argentina and Brazil (2004) IP protection is a policy instrument the operation of which may, in actual practice, produce benefits
More informationThe Interface Between Public Health, Trade & TRIPS: Current Work at the WTO and How it Relates to the Generic Industry
15 th Annual IGPA Conference Kyoto, Japan, 5 December 2012 The Interface Between Public Health, Trade & TRIPS: Current Work at the WTO and How it Relates to the Generic Industry Roger Kampf, WTO Secretariat
More informationWIPO-WTO Colloquium for Teachers of Intellectual Property
E WORLD TRADE ORGANIZATION COLLOQUIUM WIPO-WTO/COL/18/INF1.PROV ORIGINAL: ENGLISH DATE: JANUARY 2018 WIPO-WTO Colloquium for Teachers of Intellectual Property organized by the World Intellectual Property
More informationMultilateral negotiations on IP - Traditional Knowledge and Genetic resources
Multilateral negotiations on IP - Traditional Knowledge and Genetic resources Alejandro Neyra Lima, March 2010 Intellectual property multilateral negotiations WIPO treaties/processes WTO: TRIPS Agreement
More informationStatement by the BIAC Committee on Technology and Industry on THE IMPACT OF INTELLECTUAL PROPERTY PROTECTION ON INNOVATION AND TECHNOLOGY DEVELOPMENT
Business and Industry Advisory Committee to the OECD OECD Comité Consultatif Economique et Industriel Auprès de l l OCDE Statement by the BIAC Committee on Technology and Industry on THE IMPACT OF INTELLECTUAL
More informationAn Overview of Progress in the International Regulation of the Pharmaceutical Industry
University of New Hampshire Law Review Volume 1 Number 1 Pierce Law Review, Volume 1, Numbers 1 & 2 (2002) Article 10 December 2002 An Overview of Progress in the International Regulation of the Pharmaceutical
More informationThe FTAA, Access to HIV/AIDS Treatment, and Human Rights A Human Rights Watch Briefing Paper
HIV/AIDS & Human Rights Program The FTAA, Access to HIV/AIDS Treatment, and Human Rights A Human Rights Watch Briefing Paper October 29, 2002 I. Introduction Less than a year after the signing of the 2001
More informationTopic 2: The Critical Role of IP Policies in Modern Economies
Topic 2: The Critical Role of IP Policies in Modern Economies McLean Sibanda Partner: Sibanda & Zantwijk Attorneys, South Africa THE ROLE OF INTELLECTUAL PROPERTY OFFICES (IPOs) IN PROMOTING INNOVATION,
More informationNitya Nanda. The Energy and Resources Institute (TERI)
Nitya Nanda The Energy and Resources Institute (TERI) Arguments for and against patent protection The climate change context Perspectives on IPR and technology transfer Patent regimes in developing countries
More informationA Brief History of IP & Patents: Drawing Lessons from the Past
A Brief History of IP & Patents: Drawing Lessons from the Past Asean Workshop on Compulsory Licensing to Increase Access to Antiretrovirals (ARVs) and Diagnostic Reagents Kuala Lumpur, Malaysia, May 2006
More informationA short trip through Trade-related aspects of Intellectual Property Rights (TRIPS) ->START
A short trip through Trade-related aspects of Intellectual Property Rights (TRIPS) ->START Objectives of the course The purpose of this course is to help you: Understand what are intellectual property
More informationTrade, TRIPS+ & Access to Medicines
Trade, TRIPS+ & Access to Medicines Global Health Summer School Berlin, 20 September 2013 Tessel Mellema Health Action International (HAI) Europe This document arises f rom the HAI Europe s Operating Grant
More informationCOMPLIANCE OF CANADA S UTILITY DOCTRINE WITH INTERNATIONAL MINIMUM STANDARDS OF PATENT PROTECTION
COMPLIANCE OF CANADA S UTILITY DOCTRINE WITH INTERNATIONAL MINIMUM STANDARDS OF PATENT PROTECTION Jerome H. Reichman Duke Law School April 11, 2014 1 E. Richard Gold & Michael Short The Promise of the
More informationPatent Working Requirements Historical and Comparative Perspectives
Patent Working Requirements Historical and Comparative Perspectives Marketa Trimble Professor of Law William S. Boyd School of Law Patent Sovereignty and International Law UC Irvine School of Law October
More informationPatenting, Innovation & Technology Transfer : The CSIR Experience
Publically funded patents and technology transfer: A review of the Indian Bayh- Dole bill. Patenting, Innovation & Technology Transfer : The CSIR Dr. Rekha Chaturvedi Head, IPR Cell National University
More informationUNCTAD-ICTSD Project on IPRs and Sustainable Development
UNCTAD-ICTSD Project on IPRs and Sustainable Development 1 Overview Since the early 1990s, Intellectual Property (IP) policy has become one of the most economically and politically contentious issues in
More informationStanding Committee on the Law of Patents
E SCP/15/INF/2 ORIGINAL: ENGLISH DATE: JULY 20, 2010 Standing Committee on the Law of Patents Fifteenth Session Geneva, October 11 to 15, 2010 STATUS OF WORK RELATING TO THE NON-EXHAUSTIVE LIST OF ISSUES
More informationWIPO Development Agenda
WIPO Development Agenda William New William New Intellectual Property Watch Geneva wnew@ip-watch.ch WIPO Development Agenda* Background to Agreement 2007 Development Agenda Availability of Information
More informationIN THE MATTER OF THE ANTI-CONTERFEITING TRADE AGREEMENT. Docket No.: USTR COMMENTS OF PUBLIC KNOWLEDGE
IN THE MATTER OF THE ANTI-CONTERFEITING TRADE AGREEMENT Docket No.: USTR-2010-0014 Introduction COMMENTS OF PUBLIC KNOWLEDGE Public Knowledge submits these comments in the above-mentioned docket. As the
More informationMEDICINES ACCESS AND INNOVATION IN DEVELOPING COUNTRIES. A Review by Europe Economics
MEDICINES ACCESS AND INNOVATION IN DEVELOPING COUNTRIES A Review by Europe Economics Europe Economics Chancery House 53-64 Chancery Lane London WC2A 1QU Tel: (+44) (0) 20 7831 4717 Fax: (+44) (0) 20 7831
More informationDetailed Presentation of Trade and technology transfer
WTO E-LEARNING COPYRIGHT 12 Detailed Presentation of Trade and technology transfer OBJECTIVES Describe the relationship between trade and transfer of technology; Explain the provisions relating to trade
More informationISAS Insights. Drug Patents in India: Turf Battles. Amitendu Palit 1. No April 2013
ISAS Insights No. 203 8 April 2013 469A Bukit Timah Road #07-01, Tower Block, Singapore 259770 Tel: 6516 6179 / 6516 4239 Fax: 6776 7505 / 6314 5447 Email: isassec@nus.edu.sg Website: www.isas.nus.edu.sg
More information5 th Annual Pharma IPR Conference 2016
5 th Annual Pharma IPR Conference 2016 9 11 March 2016, Mumbai DAY 1 : 9 th March 2016 Country: US 09:40 American Invents Act Updates on Americas Invents Act and current scenario of US Patent laws Implications
More informationPATENTS, INTERNATIONAL TRADE LAW AND ACCESS TO ESSENTIAL MEDICINES
PATENTS, INTERNATIONAL TRADE LAW AND ACCESS TO ESSENTIAL MEDICINES BY RICHARD ELLIOTT AND MARIE-HÉLÈNE BONIN What is the issue? More than 85% of the world s population live in developing countries, and
More informationBOOK REVIEW INTELLECTUAL PROPERTY, PHARMACEUTICALS AND PUBLIC HEALTH: ACCESS TO DRUGS IN DEVELOPING COUNTRIES
(2014) 11:3 SCRIPTed 332 BOOK REVIEW INTELLECTUAL PROPERTY, PHARMACEUTICALS AND PUBLIC HEALTH: ACCESS TO DRUGS IN DEVELOPING COUNTRIES By Kenneth C. Shadlen, Samira Guennif, Alenka Guzmán and N. Lalitha
More informationThe Green Economy: Trade and Sustainable Development Implications. From Rio to Rio:Technology Transfer, Innovation and Intellectual Property
Ad Hoc Expert Meeting on The Green Economy: Trade and Sustainable Development Implications Geneva, Switzerland. 8-10 Nov 2011 From Rio to Rio:Technology Transfer, and Intellectual Property By Mr. Ahmed
More information1. TRIPS, intellectual property rights and access to medicines a,b
UHC Technical brief 1. TRIPS, intellectual property rights and access to medicines a,b What is the TRIPS Agreement? The Agreement on Trade-Related Aspects of Intellectual Property Rights (or the TRIPS
More informationCounterfeit, Falsified and Substandard Medicines
Meeting Summary Counterfeit, Falsified and Substandard Medicines Charles Clift Senior Research Consultant, Centre on Global Health Security December 2010 The views expressed in this document are the sole
More informationKaminiShanmugaiah 1. Introduction
THE LEGAL CHALLENGES FACED BY THE PHARMACEUTICAL INDUSTRY PARTICULARLY IN INDIA: AN ANALYSIS OF THE COMPULSORY LICENSING SYSTEM AND SECTION 3(D) OF THE PATENTS AMENDMENT ACT 2005 KaminiShanmugaiah 1 The
More informationThe 45 Adopted Recommendations under the WIPO Development Agenda
The 45 Adopted Recommendations under the WIPO Development Agenda * Recommendations with an asterisk were identified by the 2007 General Assembly for immediate implementation Cluster A: Technical Assistance
More informationRECENT INTERNATIONAL DEVELOPMENTS IN THE AREA OF INTELLECTUAL PROPERTY RIGHTS
RECENT INTERNATIONAL DEVELOPMENTS IN THE AREA OF INTELLECTUAL PROPERTY RIGHTS This paper examines some of the recent international developments in the area of IPRs: the interim implementation of paragraph
More informationHistorical Background, General Provisions and Basic Principles of the TRIPS Agreement and Transitional Arrangements*
J:mrnal ofinoollectual Property Rights Vol 3 March 1998 pp 68-73 Historical Background, General Provisions and Basic Principles of the TRIPS Agreement and Transitional Arrangements* Mart Leesti Former
More informationHIV and co-infection medicines
IP and regulatory barriers in LMICs HIV and co-infection medicines APACC, 2018 Hongkong, June 2018 Monopolies linked to Prices Monopoly No monopoly One supplier Multiple suppliers No competition Competition
More informationAmericas Trade and Sustainable Development Forum (ATSDF) November 2003, Miami. Trade, Knowledge and Intellectual Property Rights Thematic Tent
Americas Trade and Sustainable Development Forum (ATSDF) 17-18 November 2003, Miami Trade, Knowledge and Intellectual Property Rights Thematic Tent CONCLUSIONS On behalf of the Trade, Knowledge and Intellectual
More informationStatement by Executive Director, South Centre, Martin Khor, to the Open Working Group on Sustainable Development Goals, 9 Dec 2013
Statement by Executive Director, South Centre, Martin Khor, to the Open Working Group on Sustainable Development Goals, 9 Dec 2013 1. MEANS OF IMPLEMENTATION AND GLOBAL PARTNERSHIP FOR DEVELOPMENT The
More informationAccess and Benefit Sharing: Case studies and International experience
Access and Benefit Sharing: Case studies and International experience Palpu Pushpangadan palpuprakulam@yahoo.co.in Amity Institute for Herbal and Biotech Products Development Peroorkada. P.O. Trivandrum,
More informationAAAS Project on Science and Intellectual Property in the Public Interest
AAAS Project on Science and Intellectual Property in the Public Interest Bringing a public interest perspective to science and intellectual property issues, by: Examining the effects of IPRs on science
More informationSustainable development
Guillaume Henry Joël Ruet Matthieu Wemaëre Sustainable development & INTELLECTUAL PROPERTY Access to technologies in developing countries Overview Sustainable development, this meta-project that aims to
More informationWIPO: Working on the balance
WIPO: Working on the balance Use and Abuse of IP and Related Rights : Getting the Right Balance Second Session October 17, 2010 Matthew Bryan, Director, Patent Cooperation Treaty Legal Division Trolls
More informationINDIA Market Projections and Developments
The Seventh Annual IGPA Conference INDIA Market Projections and Developments by D G Shah Secretary General Indian Pharmaceutical Alliance Prague: June 2004 1 Potential & Problems Indian Pharmaceutical
More information